Crizotinib

C21H22Cl2FN5O

450.34

1308068-62

可唑替尼; 克卓替尼; 克唑替尼; 克里唑替尼API; 克卓替尼, 克里唑替尼; (R)-3-(1-(2,6-二氯-3-氟苯基)乙氧基)-5-(1-(哌啶-4-基)-1H-吡唑-4-基)吡啶-2-胺(克唑替尼); 克; 克里唑替尼,CRIZOTINIB; <a target="_blank" href="/ProductDict_211.htm">克里唑替尼</a>;

(R)-3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H- pyrazol-4-yl)pyridin-2-ylaMine; [3-[[(R)-1-(2,6-Dichloro-3- fluorophenyl)ethyl]oxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-yl]aMine; 2-PyridinaMine, 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-; Crozotinib; Crizotinib (PF2341066); PF-02341066 Crizotinib; 3-((R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine; k-ras(g12c) inhibitor 6 NA Crizotinib;